Nurix Therapeutics (NRIX) Enterprise Value (QoQ) (2019 - 2026)
Nurix Therapeutics (NRIX) Enterprise Value (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - |
| 4 | BeOne Medicines | 468.98 Bn | 464.19 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.24 Bn | 115.99 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.45 Bn | 61.70 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.04 Bn | 63.04 Bn | - |
| 8 | Argenx Se | 55.79 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn |
| 10 | Nurix Therapeutics | 2.61 Bn | 2.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 17.98% |
| Feb 28, 2026 | 8.81% |
| Nov 30, 2025 | -38.27% |
| Aug 31, 2025 | 11.72% |
| May 31, 2025 | 11.62% |
| Feb 28, 2025 | 9.83% |
| Nov 30, 2024 | -36.05% |
| Aug 31, 2024 | -1.11% |
| May 31, 2024 | -81.62% |
| Feb 29, 2024 | 15.25% |
| Nov 30, 2023 | -11.22% |
| Aug 31, 2023 | 7.94% |
| May 31, 2023 | -1.45% |
| Feb 28, 2023 | 10.35% |
| Nov 30, 2022 | 10.26% |
| Aug 31, 2022 | -15.88% |
| May 31, 2022 | -13.47% |
| Feb 28, 2022 | 11.41% |
| Nov 30, 2021 | 14.01% |
| Aug 31, 2021 | 10.91% |